Hong Kong, China

Wanxia Gai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Grail, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanxia Gai. Retrieved from https://idiyas.com/inventor/wanxia-gai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wanxia Gai: Innovator in Tissue-Specific Methylation Markers

Introduction

Wanxia Gai is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of molecular biology, particularly in the identification of tissue-specific markers. His work has implications for cancer detection and understanding the origins of cell-free nucleic acids.

Latest Patents

Wanxia Gai holds 1 patent related to a tissue-specific methylation marker. This patent provides compositions that comprise tissue-specific markers for identifying the tissue of origin of a cell-free nucleic acid, such as a cell-free DNA molecule. The patent also outlines methods, compositions, and systems for identifying the tissue of origin by determining the absolute amount of cell-free nucleic acids that include the tissue-specific marker. Furthermore, it describes methods for detecting cancer in a tissue by analyzing these markers.

Career Highlights

Wanxia Gai is associated with Grail, Inc., a company focused on early cancer detection through innovative technologies. His work at Grail has positioned him as a key figure in the development of advanced diagnostic tools.

Collaborations

He has collaborated with notable colleagues, including Yuk-Ming Dennis Lo and Rossa Wai Kwun Chiu, who are also recognized for their contributions to the field of cancer research and diagnostics.

Conclusion

Wanxia Gai's innovative work in tissue-specific methylation markers represents a significant advancement in cancer detection and molecular biology. His contributions continue to influence the field and pave the way for future research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…